Corbevax gets DCGI nod for use as booster jab

Hyderabad-based Biological E Limited’s Covid-19 vaccine Corbevax has emerged as the first vaccine to bag approval from the Drug Controller General of India for use as a heterologous booster dose, for those aged 18 years and above, after 6 months of administration of the second dose of either Covaxin or Covishield.

from Times of India https://ift.tt/dNMwzTC
https://ift.tt/uLUz4W8 June 04, 2022 at 04:32PM

Comments

Popular posts from this blog

Covid live: Record 50,000+ infections on Sunday

Impact of pandemic? Women jobseekers fell by 34% in 2021

SC slams trial courts for seeking needless custody